South Dakota 2024 Regular Session

South Dakota Senate Bill SB198

Introduced
1/31/24  
Refer
1/31/24  
Report Pass
2/14/24  
Engrossed
2/20/24  
Refer
2/21/24  
Report Pass
2/27/24  
Enrolled
2/29/24  

Caption

Authorize school districts and nonpublic schools to acquire and administer nasal glucagon.

Impact

The bill establishes specific protocols for school districts and nonpublic schools regarding the procurement and administration of nasal glucagon. Schools are required to maintain secure storage of the medication and ensure that designated personnel receive training about administering glucagon and identifying symptoms of hypoglycemia. By adopting this legislation, South Dakota acknowledges the critical need for emergency measures in schools, thus enhancing the overall capability of educational staff to deal effectively with medical emergencies involving diabetic students.

Summary

Senate Bill 198, entitled 'An Act to authorize school districts and nonpublic schools to acquire and administer nasal glucagon', aims to empower educational institutions in South Dakota to provide immediate medical assistance for students experiencing severe hypoglycemia due to diabetes. The bill specifies that school nurses or authorized personnel can administer nasal glucagon, a vital medication, in urgent situations where a student’s prescribed glucagon is unavailable or expired. This initiative is geared towards promoting student health and safety in school environments, especially for those diagnosed with diabetes.

Sentiment

The sentiment surrounding SB198 appears to be overwhelmingly positive among legislators and healthcare advocates. Proponents argue that the measure not only safeguards the well-being of students suffering from diabetes but also reduces the barriers that could delay urgent medical intervention. They highlight the importance of having the ability to respond swiftly to hypoglycemic events on school premises. The emphasis on training suggests a commitment to ensuring that employees are well-prepared and confident when administering care, which contributes to a supportive and health-conscious educational environment.

Contention

While the bill gains general support, potential areas of concern could involve the implementation of training requirements and the logistics of maintaining appropriate standards for medication storage and administration. Some stakeholders may question the adequacy of training for school staff and how it might affect their educational duties. Furthermore, ensuring that all local districts can access necessary resources to implement these measures uniformly across different schools may present challenges that need to be addressed as the legislation moves forward.

Companion Bills

No companion bills found.

Similar Bills

NJ A1882

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

NJ A5066

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

WV SB92

Glucagon for Schools Act

FL H0597

Diabetes Management in Schools

WV SB195

Glucagon for Schools Act

WV SB293

Creating the Glucagon for Schools Act

DC B25-0226

Access to Emergency Albuterol and Glucagon Amendment Act of 2023 (now known as "Access to Emergency Medications Amendment Act of 2023")

TX HB350

Relating to the use of glucagon medication on certain public and private school campuses.